The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Increased serum advanced glycation end‐products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)
Open accessAbstract
Summary: Background Nonenzymatic advanced glycation and oxidation end‐products, advanced glycation end‐products (AGEs), impart a potent impact on vessels and other tissues in diabetic state and in euglycaemic conditions with increased oxidative stress. Insulin resistant (IR) polycystic ovary syndrome (PCOS) women, have elevated serum AGEs, increased receptor (RAGE) expression, and increased deposition with differential localization in the polycystic ovarian tissue (theca and granulosa) compared to normal. Objective To determine whether the raised AGE levels in noninsulin resistant women with PCOS is a distinct finding compared with those presenting the isolated components of the syndrome and among PCOS subphenotypes. Noninsulin resistant women were selected in order to show that serum AGEs are elevated in PCOS independently of the presence of IR. Design Clinical trial. Patients One hundred and ninety‐three age‐ and BMI‐matched young lean noninsulin resistant women were studied. Among them, 100 women were diagnosed with PCOS according to Rotterdam criteria, and divided to subphenotypes (hyperandrogenaemia with or without PCO morphology and with or without anovulation). Sixty‐eight women with the isolated components of the PCOS phenotype were also studied along with 25 healthy women. Measurements Serum AGE levels, metabolic, hormonal profiles and intravaginal ultrasound were determined in all subjects. Results The studied population did not differ in BMI, fasting insulin concentration, waist : hip and glucose : insulin ratios. PCOS women exhibited statistically higher AGEs levels (7·96 ± 1·87 U/ml, P < 0·001) compared with those with isolated hyperandrogenaemia (5·61 ± 0·61 U/ml), anovulation (5·53 ± 1·06 U/ml), US‐PCO morphology (5·26 ± 0·25 U/ml) and controls (5·86 ± 0·89 U/ml). Conclusions In PCOS, serum AGEs are distinctly elevated compared with women having the isolated characteristics of the syndrome. No difference was observed between PCOS subphenotypes. As chronic inflammation and increased oxidant stress have been incriminated in the pathophysiology of PCOS, the role of AGEs as inflammatory and oxidant mediators, may be linked with the metabolic and reproductive abnormalities of the syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Advanced glycation end-products: A review
Singh, R., Barden, A., Mori, T., & Beilin, L. (2001) · Diabetologia · doi:10.1007/s001250051591 · Cited by 2,597
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann, D. A., Barnes, R. B., Rosenfield, R. L., Cavaghan, M. K., & Imperial, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.141 · Cited by 1,257
Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS)
Dunaif, A., Wu, X., Lee, A., & Diamanti-Kandarakis, E. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.2.e392 · Cited by 337
Self-citationBirdsall, M. A., Farquhar, C. M., & White, H. D. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-1-199701010-00005 · Cited by 327
Barber, T. M., Wass, J. A. H., McCarthy, M. I., & Franks, S. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02764.x · Cited by 254
Lu, C., He, J. C., Cai, W., Liu, H., Zhu, L., & Vlassara, H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401588101 · Cited by 228
Involvement of Hydrogen Peroxide in Collagen Cross-linking by High Glucose in Vitro and in Vivo
Elgawish, A., Glomb, M., Friedlander, M., & Monnier, V. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.12964 · Cited by 201
Research works printed but not linked: 34
- 10.1210/jcem.84.11.6148 · DOI · Paper page
- 10.1016/S1043-2760(96)00125-7 · DOI
- 10.1016/S0889-8529(05)70075-X · DOI
- 10.2337/diab.38.9.1165 · DOI · Paper page
- 10.1210/er.18.6.774 · DOI · Paper page
- 10.1111/j.1365-2265.1992.tb02295.x · DOI · Paper page
- 10.1016/j.tem.2007.07.004 · DOI · Paper page
- 10.1161/01.ATV.15.7.821 · DOI · Paper page
- 10.1055/s-2007-1016308 · DOI
- 10.3109/00016349209006227 · DOI · Paper page
- Vlassara H., 1994, Recent progress on the biologic and clinical significance of advanced glycosylation end products, Journal of Laboratory Clinical Medicine, 124, 19
- 10.1038/ki.1995.322 · DOI
- 10.1172/JCI116482 · DOI · Paper page
- 10.1073/pnas.94.25.13915 · DOI · Paper page
- 10.1016/S0272-6386(03)00779-0 · DOI · Paper page
- 10.1093/jb/mvh193 · DOI
- 10.2337/diab.40.4.405 · DOI · Paper page
- 10.2165/00002512-199609020-00001 · DOI · Paper page
- 10.1074/jbc.M301088200 · DOI
- 10.1254/jphs.CPJ04005X · DOI
- 10.1161/hc0702.104183 · DOI · Paper page
- 10.1074/jbc.273.15.8630 · DOI
- 10.1111/j.1365-2265.2004.02170.x · DOI · Paper page
- 10.1210/jc.2003-031205 · DOI · Paper page
- 10.1210/jc.2004-2279 · DOI · Paper page
- 10.1210/jc.2004-0628 · DOI · Paper page
- 10.2337/dc06-0531 · DOI · Paper page
- 10.1007/s00418-006-0265-3 · DOI · Paper page
- 10.1007/s00109-007-0246-6 · DOI
- 10.1021/bi00046a020 · DOI
- 10.1172/JCI119599 · DOI
- 10.1042/bj2450243 · DOI · Paper page
- 10.1210/jc.2005-1696 · DOI · Paper page
- 10.1016/S0015-0282(03)00571-5 · DOI · Paper page
Cited by
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
Diamanti-Kandarakis, E., Bourguignon, J.-P., Giudice, L. C., Hauser, R., Prins, G. S., Soto, A. M., Zoeller, R. T., & Gore, A. C. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0002 · Cited by 4,585
Self-citationThe polycystic ovary syndrome: a position statement from the European Society of Endocrinology
Conway, G., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Franks, S., Gambineri, A., Kelestimur, F., Macut, D., Micic, D., Pasquali, R., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0253 · Cited by 676
Self-citationQiao, J., & Feng, H. L. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq032 · Cited by 479
Kandaraki, E., Chatzigeorgiou, A., Livadas, S., Palioura, E., Economou, F., Koutsilieris, M., Palimeri, S., Panidis, D., & Diamanti-Kandarakis, E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1658 · Cited by 384
Self-citationIs PCOS an inflammatory process?
Duleba, A. J., & Dokras, A. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.11.023 · Cited by 327
Metadata
- Authors
- Diamanti‐Kandarakis, E., Katsikis, I., Piperi, C., Kandaraki, E., Piouka, A., Papavassiliou, A. G., & Panidis, D.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2008-09-10
- Volume
- 69
- Issue
- 4
- Pages
- 634-641
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2069811052
- Cited by
- 174
- References
- 7
- FWCI
- 9.51
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increased serum advanced glycation end‐products is a distinct finding in lean women with polycystic ovary syndrome (PCOS). https://app.cochat.ai/papers/10.1111/j.1365-2265.2008.03247.x
- The paper
- Diamanti‐Kandarakis, E., Katsikis, I., Piperi, C., Kandaraki, E., Piouka, A., Papavassiliou, A. G., & Panidis, D. (2008). Increased serum advanced glycation end‐products is a distinct finding in lean women with polycystic ovary syndrome (PCOS). Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.2008.03247.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.